Biology Reference
In-Depth Information
10. For an optimal real-time PCR effi ciency of 2.00 per cycle, the
amplicon length should not exceed 150 bp.
11. When selecting the appropriate HKG, the following guidelines
should be considered:
The expression level of the HKG should be approximately
the same Ct value, whereas the Ct values of the target genes
can differ. Ideally, the change in the mean (the sample mean
minus the control mean) for HKGs should be between 0.5 and
0.9 and should not exceed 1. If the change in the mean is
greater than 1.5, it cannot be accepted as “not regulated”;
therefore, it cannot be used as an appropriate HKG for further
calculations.
12. For the separation of shorter fragments, a mixture of
HR-agarose and NuSieve agarose is recommended. BMA
NuSieve 3:1 agarose is suitable for the fi ne separation of small
(less than 1,000 bp) DNA fragments because of its high melt-
ing point (<90 °C) and low background fl uorescence. The
NuSieve agarose alone is very brittle and is diffi cult to handle;
therefore, it is recommended to mix the NuSieve with normal
agarose at a ratio of 1:1.
References
1. Karube Y, Tanaka H, Osada H, Tomida S,
Tatematsu Y, Yanagisawa K, Yatabe Y,
Takamizawa J, Miyoshi S, Mitsudomi T,
Takahashi T (2005) Reduced expression of Dicer
associated with poor prognosis in lung cancer
patients. Cancer Sci 96(2):111-115. doi: CAS015
[pii]10.1111/j.1349-7006.2005.00015.x
5. Dedes KJ, Natrajan R, Lambros MB, Geyer
FC, Lopez-Garcia MA, Savage K, Jones RL,
Reis-Filho JS (2011) Down-regulation of the
miRNA master regulators Drosha and Dicer is
associated with specifi c subgroups of breast
cancer. Eur J Cancer 47(1):138-150.
doi: S0959-8049(10)00788-4 [pii]10.1016/j.
ejca.2010.08.007
6. Valencak J, Schmid K, Trautinger F, Wallnofer
W, Muellauer L, Soleiman A, Knobler R, Haitel
A, Pehamberger H, Raderer M (2011) High
expression of Dicer reveals a negative prognos-
tic infl uence in certain subtypes of primary
cutaneous T cell lymphomas. J Dermatol Sci
64(3):185-190. doi: S0923-1811(11)00259-3
[pii]10.1016/j.jdermsci.2011.08.011
7. Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J,
Luo Z, Tang H, Deng M, Zheng Y, Wang R,
Zhang W, Li G (2012) The microRNA-
processing enzymes: Drosha and Dicer can
predict prognosis of nasopharyngeal carci-
noma. J Cancer Res Clin Oncol 138(1):49-56.
doi: 10.1007/s00432-011-1058-1
8. Papachristou DJ, Rao UN, Korpetinou A,
Giannopoulou E, Sklirou E, Kontogeorgakos
V, Kalofonos HP (2012) Prognostic signifi -
cance of Dicer cellular levels in soft tissue sar-
comas. Cancer Invest 30(2):172-179. doi: 10.
3109/07357907.2011.633293
9. Zhu DX, Fan L, Lu RN, Fang C, Shen WY,
Zou ZJ, Wang YH, Zhu HY, Miao KR, Liu P,
2. Chiosea SI, Barnes EL, Lai SY, Egloff AM,
Sargent RL, Hunt JL, Seethala RR (2008)
Mucoepidermoid carcinoma of upper aerodi-
gestive tract: clinicopathologic study of 78
cases with immunohistochemical analysis of
Dicer expression. Virchows Arch 452(6):629-
635. doi: 10.1007/s00428-007-0574-5
3. Grelier G, Voirin N, Ay AS, Cox DG, Chabaud
S, Treilleux I, Leon-Goddard S, Rimokh R,
Mikaelian I, Venoux C, Puisieux A, Lasset C,
Moyret-Lalle C (2009) Prognostic value of
Dicer expression in human breast cancers and
association with the mesenchymal phenotype.
Br J Cancer 101(4):673-683. doi: 6605193
[pii]10.1038/sj.bjc.6605193
4. Faggad A, Budczies J, Tchernitsa O, Darb-
Esfahani S, Sehouli J, Muller BM, Wirtz R,
Chekerov R, Weichert W, Sinn B, Mucha C,
Elwali NE, Schafer R, Dietel M, Denkert C
(2010) Prognostic signifi cance of Dicer
expression in ovarian cancer-link to global
microRNA changes and oestrogen receptor
expression.
J
Pathol
220(3):382-391.
doi: 10.1002/path.2658
Search WWH ::




Custom Search